“Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation - PubMed” https://t.co/IhhhecLqoR
8,185 followers
0 followers
”We observed a lower number of major bleedings with factor Xa inhibitors (apixaban, edoxaban,rivaroxaban) compared with warfarin (OR 0.80, 95% CI 0.72 to 0.90)” Keep in mind that there was significant heterogeneity in this analysis. #WarfarinVsNOAC https:/
299 followers
#CochraneEvidence: Treatment with factor Xa inhibitors significantly reduced the number of strokes and systemic embolic events compared with warfarin in people with AF. https://t.co/PKlpd5HPKh
8,044 followers
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation. - PubMed - NCBI https://t.co/flng4z0Qnr